Literature DB >> 9706432

Coexistence of Fabry's disease and systemic lupus erythematosus.

P Rahman1, D D Gladman, J Wither, M D Silver.   

Abstract

This report describes a case of a female with systemic lupus erythematosus, who was subsequently diagnosed with Fabry's disease. Due to similarities in the organs involved by these two multisystem disorders, difficulties were encountered in establishing a prompt diagnosis of Fabry's disease. That and subsequent management of this patient are discussed. A literature review of the coexistence of the two disorders along with the potential pathogenic mechanisms explaining this association are explored.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9706432

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  14 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Attila D Kovács; David A Pearce
Journal:  Biochim Biophys Acta       Date:  2016-04-19

3.  Zebra bodies without Fabry disease or hydroxychloroquine.

Authors:  Keita Kadosawa; Takashi Morikawa; Yoshio Konishi
Journal:  Clin Exp Nephrol       Date:  2020-09-11       Impact factor: 2.801

4.  IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.

Authors:  Catharina Whybra; Andreas Schwarting; Jörg Kriegsmann; Andreas Gal; Eugen Mengel; Christoph Kampmann; Frank Baehner; Ellen Schaefer; Michael Beck
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

5.  Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities.

Authors:  David F Moore; Oleg V Krokhin; Ronald C Beavis; Markus Ries; Chevalia Robinson; Ehud Goldin; Roscoe O Brady; John A Wilkins; Raphael Schiffmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

6.  High incidence of autoantibodies in Fabry disease patients.

Authors:  P Martinez; M Aggio; P Rozenfeld
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

7.  Leukocyte perturbation associated with Fabry disease.

Authors:  P Rozenfeld; E Agriello; N De Francesco; P Martinez; C Fossati
Journal:  J Inherit Metab Dis       Date:  2009-03-07       Impact factor: 4.982

8.  Screening for Fabry Disease in Patients With Juvenile Systemic Lupus Erythematosus.

Authors:  Ertugrul Kiykim; Sezgin Şahİn; Tanyel ZubarioĞlu; Kenan Barut; Amra Adrovic; Mehmet Şerif Cansever; Ayşe Çiğdem AktuĞlu Zeybek; Özgür KasapÇopur
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

9.  Fabry's disease: An ultrastructural study of nerve biopsy.

Authors:  N Gayathri; T C Yasha; Makarand Kanjalkar; Santosh Agarwal; B K Chandrashekar Sagar; Vani Santosh; S K Shankar
Journal:  Ann Indian Acad Neurol       Date:  2008-07       Impact factor: 1.383

10.  Frequency of Fabry disease in a juvenile idiopathic arthritis cohort.

Authors:  Luciana Paim-Marques; Amanda Virginia Cavalcante; Islane Verçosa; Paula Carneiro; Marcia Souto-Maior; Erlane Marques; Simone Appenzeller
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-12       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.